---
title: 'Antiarrhythmic drugs will no longer be of importance in the treatment of atrial
  fibrillation in the future : Pros and cons'
date: '2024-11-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39535618/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241113193351&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: An early rhythm stabilization is the primary focus of the current treatment
  of atrial fibrillation. Based on current studies catheter ablation of pulmonary
  vein isolation (PVI) is an established component in the treatment of atrial fibrillation.
  Therefore, in the management of affected patients this procedure should be offered
  at an early stage in addition to the holistic treatment approach with consistent
  treatment of cardiovascular risk factors and thromboembolism prophylaxis ...
disable_comments: true
---
An early rhythm stabilization is the primary focus of the current treatment of atrial fibrillation. Based on current studies catheter ablation of pulmonary vein isolation (PVI) is an established component in the treatment of atrial fibrillation. Therefore, in the management of affected patients this procedure should be offered at an early stage in addition to the holistic treatment approach with consistent treatment of cardiovascular risk factors and thromboembolism prophylaxis ...